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Original repOrt
Antibody titration is traditionally performed using a conventional 
test tube (CTT) method, which is subjected to interlaboratory 
variations because of a lack of standardization and reproducibility. 
The aim of this study is to compare newer methods such as gel 
column technology (GCT) and erythrocyte magnetized technology 
(EMT) for antibody titration in terms of accuracy and precision. 
Patient serum samples that contained immunoglobulin G (IgG) red 
blood cell (RBC) alloantibodies of a single specificity for Rh or K 
antigens were identified during routine transfusion service testing 
and stored. Titration and scoring were performed separately by 
different laboratory personnel on CTT, GCT, and EMT. Testing 
was performed a total of three times on each sample. Results 
were analyzed for accuracy and precision. A total of 50 samples 
were tested. Only 20 percent of samples tested with GCT showed 
titers identical to CTT, whereas 48 percent of samples tested with 
EMT showed titers identical to CTT. Overall, the mean of the titer 
difference from CTT was higher using GCT (+0.31) compared with 
that using EMT (+0.13). Precision shown by CTT was 30 percent, 
EMT was 76 percent, and GCT was 92 percent on repeat testing. 
GCT showed higher titer values in comparison with CTT but was 
found to be the most precise. EMT titers were comparable to CTT, 
and its precision was intermediate. Further studies to validate this 
method are required. Immunohematology 2015;31:1–6.
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Titration is performed to assess the concentration and 
strength of antibodies semiquantitatively in serum or eluate 
samples. This procedure is quite technique dependent1 
and inherently subjected to interlaboratory variations in 
accuracy and precision. Conventional test tube (CTT) is the 
recommended method for performing red blood cell (RBC) 
alloantibody titrations in transfusion medicine laboratories, 
but the method has been criticized because of concerns about 
inaccuracy, relatively poor reproducibility, and the subjectivity 
in interpretation of the titer end point.2 In recent years, several 
new methods have found their place in transfusion medicine 
laboratories for RBC serology and are suitable because of their 
accuracy, reproducibility, and precision.
In 1990, Lapierre et al.3 introduced a column agglutination 
method, which gained popularity because of its standardized 
performance, technical ease, stable end point, and the 
versatility of the method. This method is presently used 
worldwide and has been reported to be more sensitive for 
detection and identification of RBC alloantibodies.4,5 However, 
on performing the titration studies with gel column technology 
(GCT), researchers have found no linear correlation and 
several-fold higher titers in comparison with CTT.6,7 This may 
lead to overestimation of the antibody’s strength and, hence, 
clinical decisions toward more invasive interventions for 
patients who develop the antibody.
A recent introduction in the field of transfusion medicine 
is erythrocyte magnetized technology (EMT) (Fig. 1). This 
method is based on the adsorption of paramagnetic particles 
in the presence of an externally applied magnetic field on the 
membrane of the RBCs. Thus, after contact with antibodies, 
reactive and nonreactive magnetized RBCs are rapidly pulled 
Fig. 1. Instrumentation for erythrocyte magnetized technology.
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to the bottom of the well when placed on a magnetic plate. A 
final phase of shaking reveals positive or negative reactions, 
with no need for centrifugation (Fig. 2). The method has been 
found to be highly reliable for evaluating ABO grouping, Rh 
phenotyping, K typing, and antibody detection.8 To the best of 
our knowledge, no major study has been conducted so far for 
evaluating antibody titration using EMT.
This study was conducted to determine which method 
(GCT versus EMT) is a better substitute for replacing the 
age-old, gold standard of CTT for titration studies in terms 
of accuracy and precision. Precision serves as a more useful 
indicator of the method’s ability to reproducibly predict a 
rise in titer and not simply a variation observed as a result of 
individual technique.
Materials and Methods
The study was conducted at a transfusion medicine 
department of a tertiary care hospital and research center in 
North India. Blood samples that contained immunoglobulin 
G (IgG) RBC alloantibodies of a single specificity for Rh or K 
antigens were identified during routine transfusion service 
patient testing. For this study, only samples with antibodies 
that had strength of at least 2+ by CTT were included. Sera 
were separated from clotted blood samples and stored at –18°C 
in three separate aliquots. They were thawed immediately 
before testing.
Testing was performed separately by different trained 
laboratory personnel using CTT, GCT (LISS/Coombs ID-card 
Bio-Rad Laboratories, DiaMed GmbH, Cressier, Switzerland), 
and EMT (QWALYS 3, Diagast, Loos, France) to remove the 
operator bias. Sample identity was also blinded. Titration and 
scoring for each serum sample was performed a total of three 
times. On each test day, a new master dilution was prepared 
and one aliquot of serum sample was tested by all three 
methods. For comparison of the accuracy, CTT was considered 
the reference method, and results obtained on the first testing 
of a sample were used. Results of all three trials for a particular 
sample were analyzed to determine precision.
Serum Dilution
Serial twofold dilutions were made in normal saline. 
Pipette tips were changed after the transfer of each dilution. 
Using the same master dilution tube for all three methods 
reduces the likelihood of variation in titer and score relevant to 
the preparation of serial twofold dilutions.
Reagent RBCs
Reagent RBCs for CTT and GCT were prepared from 
donors who were homozygous for the allele encoding the 
corresponding antigen for the alloantibody being titrated using 
commercial antisera (DiaClon Bio-Rad Laboratories, DiaMed 
GmbH). A suspension was prepared in normal saline for CTT 
(2%) and GCT (0.8%) using the same reagent RBCs. For EMT, 
three vials of premagnetized group O test RBCs (HemaScreen 
I, II, III), which were supplied by the manufacturer with the 
antibody detection kit (ScreenLys, Diagast), were used. As per 
the anti-gram, the reagent RBC panel cells carrying apparently 
double dose expression of the cognate antigen were selected for 
the titration study.
Titration by CTT
Titration was performed using 12 test tubes following the 
standard procedure in the AABB Technical Manual.1 Briefly, 
100 μL diluted serum was placed into each test tube, and 100 
μL of 2 percent cell suspension was then added. The tubes 
were incubated at 37°C for 60 minutes. After washing four 
times with saline, two drops of anti-IgG (AHG; Eryclon Tulip 
Diagnostics, Goa, India) were added to each tube. The tubes 
were centrifuged and read for macroscopic agglutination. In-
house prepared check cells were added to all tubes showing 
negative reaction and checked for agglutination to ensure the 
integrity of the AHG test results.
Titration by GCT
Titration was performed following the procedure used 
for antibody detection and identification. Briefly, 50 μL of 0.8 
percent reagent RBC suspension was added to the gel column, 
followed by 25 μL diluted serum sample. After a standard 
Fig. 2. Plate showing results of testing by erythrocyte magnetized 
technology. Negative reactions appear as a dot, and positive 
reactions are visualized as a cellular layer.
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15-minute incubation at 37°C, the gel cards were centrifuged 
and the reactions were immediately graded.
Titration by EMT
Titration using EMT was also performed following 
the procedure used for antibody detection, in which each 
dilution was tested as an individual sample. The machine first 
dispensed 60 μL of a high-density solution (NanoLys) that 
prevents contact between the patient’s serum and the anti-IgG 
coated on the plates (ScreenLys). Next, 60 mL diluent, 15 mL 
patient’s serum, and 15 mL test RBCs (1% suspension) were 
dispensed. The plate was incubated at 37°C for 20 minutes and 
then placed on the magnetic shaker. Sensitized cells migrated 
through the NanoLys solution and reacted with the coated 
anti-IgG at the bottom of the wells. Positive reactions appear 
as a cellular layer, and negative reactions appear as a dot at 
the bottom of the well (Fig. 2). The results reported by the 
instrument were graded from negative to 4+ depending on the 
intensity of the reaction as per the literature provided by the 
manufacturer.
Scoring and Titration End Points
For all the methods, the titer was reported as the reciprocal 
of the highest dilution of serum at which 1+ agglutination 
was observed, and the strength of reactions was scored as 
described in the AABB Technical Manual.1
Statistics
Results are presented as numbers and percentages. For 
calculating the mean differences in titer by two methods, all 
titer values were converted to a log value (the logarithm of 
the titer value to the base 2). The arithmetic mean of these 
differences was then calculated.
For determining the precision, the differences were 
calculated between the lowest and highest values of the three 
test values of titers and scores. If the results of testing three 
times show variation, the differences were termed Δ value titer 
and Δ value score, respectively.
Results
In the present study, 50 samples containing antibodies of 
six different specificities were subjected to titration with CTT, 
GCT, and EMT. Considering CTT as the reference method, 
difference in titers obtained by GCT and EMT are shown 
in Table 1. Only 20 percent of the samples tested with GCT 
showed titers identical with CTT, whereas 48 percent of the 
samples tested with EMT showed identical titers with CTT. 
In four samples, the titers with GCT were fourfold higher than 
those with CTT. In no sample were the titers by EMT that 
much higher than those with CTT (i.e., fourfold).
The mean difference in titers, calculated by converting the 
titer values to log (base 2) values for each antibody, is shown 
in Table 2. Overall, the mean difference of titer and score from 
CTT was higher with GCT (+0.31, 10.62) compared with that 
using EMT (+0.13, 4.88). The mean difference of titer between 
Table 1. Difference in titers by GCT and EMT in comparison with 
CTT
Difference in titers (vs. CTT) GCT [n (%)] EMT [n (%)]
Identical 10 (20%) 24 (48%)
Twofold
Higher 23 (46%) 16 (32%)
Lower 3 (6%) 5 (10%)
Threefold
Higher 8 (16%) 4 (8%)
Lower 2 (4%) 1 (2%)
Fourfold
Higher 4 (8%) —
Lower — —
GCT = gel column technology; EMT = erythrocyte magnetized technology; 
CTT = conventional test tube.
Table 2. Comparison of the mean difference in titer and score
Mean difference in titer Mean difference in score
Antibody specificity Number GCT–CTT EMT–CTT GCT–CTT EMT–CTT
Anti-D 32 +0.38 +0.12 12.19 7.06
Anti-E 2 +0.30 +0.15 9.50 7.0
Anti-e 6 –0.10 –0.05 2.17 3.50
Anti-C 7 +0.26 +0.17 11.58 4.72
Anti-c 1 +0.30 0 10.0 2.0
Anti-K 2 +0.45 +0.15 7.0 5.0
Total 50 +0.31 +0.13 10.62 4.88
GCT = gel column technology; CTT = conventional test tube method; EMT = erythrocyte magnetized technology.
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GCT and CTT was highest for anti-K (+0.45), followed by 
anti-D. The mean difference of score between EMT and CTT 
was highest for anti-C (+0.17). The mean difference of score 
from CTT was highest for anti-D for both GCT (12.19) and 
EMT (7.06).
Reproducibility of the methods was compared in terms 
of precision. Comparing the differences when repeating both 
the titration and scoring values (Tables 3 and 4), the highest 
precision was observed with GCT, followed by EMT, and was 
lowest with CTT. In terms of titer, absolute precision was seen 
with GCT in 92 percent of cases, EMT in 76 percent of cases, 
and CTT in 30 percent of cases. Highest precision in terms of 
score (Δ0–2) was seen with GCT in 78 percent of cases, EMT 
in 64 percent of cases, and CTT in 24 percent of cases.
Discussion
CTT is recommended for performing antibody titration, 
but this method is subject to technical variables that can affect 
the results substantially. This study was conducted to establish 
whether titrations with newer methods such as GCT and EMT 
correlate with CTT and to compare the precision of various 
methods.
There are no previous studies on antibody titration by 
EMT; however, a few studies have been conducted to evaluate 
antibody titration by EMT for ABO-Rh testing, antibody 
detection, and phenotyping, in which it demonstrated a reliable 
performance with a high sensitivity and specificity.9,10 EMT’s 
comparison with GCT demonstrated similar performance 
in detecting clinically relevant antibodies together with a 
noteworthy reduction in the number of antibodies without 
clinical importance.8 This previous information led us to 
evaluate the EMT against GCT as a suitable method for 
antibody titration.
The titration of antibodies by the three methods in the 
present study showed variable results. On comparison of the 
titers, it was observed that titers obtained by EMT correlate 
better with CTT than GCT. In nearly half of the samples (48%), 
the titers obtained by CTT and EMT were identical. However, 
with GCT, 46 percent of the samples were found to have twofold 
higher titers than CTT, and 8 percent had titers as much as 
fourfold higher in comparison with CTT. Many studies have 
been conducted in the past for comparing the titrations by 
CTT and GCT and have reported variable findings. Novaretti 
et al.6 found a strong variability in anti-D titration by GCT in 
all 79 samples tested. The observed differences were as high 
as threefold in 5 sera, fourfold in 21, fivefold in 30, sixfold in 
20, sevenfold in 2, and eightfold in 1. Thus, these authors have 
concluded that GCT should not be used for anti-D to monitor 
fetuses at risk for hemolytic disease of the fetus and newborn 
(HTFN).
Bromilow et al.11 found that 31 of 34 samples with Rh, 
K, Duffy, and Kidd alloantibodies had a higher titer score by 
GCT than CTT. Of 82 samples with Rh alloantibodies, Steiner 
et al.12 reported that only 20 (24%) had significantly higher 
titers by GCT compared with CTT. In their evaluation of 27 
samples with non-Rh antibodies, the two methods performed 
equivalently, generating titers within two serial dilutions for all 
samples. A previous study from India reported that GCT is more 
sensitive than CTT for antibody detection, but significantly 
higher titers were found in 22 (26.5%) of 83 samples tested. 
The authors thus concluded that titers obtained by GCT should 
not be relied on for clinical management of HDFN.
GCT has also been evaluated for monitoring titers of 
anti-A and anti-B in patients undergoing ABO-incompatible 
kidney transplantation performed by Shirey et al.13 They 
have found identical titer values by GCT and CTT in 26 of 50 
samples, and no sample’s titer values varied more than one 
dilution between the two methods. Other researchers have 
reported that anti-A and anti-B titers obtained by GCT were 
less variable between institutions and demonstrated better 
clinical correlation compared with titers by CTT in similar 
transplant programs.14,15
In the present study, the titer values for most of the Rh 
antibodies (D, E, C, c) were approximately one tube higher by 
GCT compared with CTT. For anti-e, the average titer values 
Table 3. Precision of various methods in terms of titer
Difference in titer* CTT GCT EMT
Δ0 15 (30%) 46 (92%) 38 (76%)
Δ1 28 (56%) 4 (8%) 11 (22%)
Δ2 5 (10%) — 1 (2%)
Δ3 2 (4%) — —
*Δ represents the highest difference in titer.
CTT = conventional test tube; GCT = gel column technology;  
EMT = erythrocyte magnetized technology.
Table 4. Precision of various methods in terms of score
Difference in score* CTT GCT EMT
Δ0–2 12 (24%) 39 (78%) 32 (64%)
Δ3–4 20 (40%) 9 (18%) 12 (24%)
Δ5–6 9 (18%) 2 (4%) 4 (8%)
Δ6–7 5 (10%) — 2 (4%)
Δ8–9 2 (4%) — —
Δ>10 2 (4%) — —
*Δ represents the highest difference in score.
CTT = conventional test tube; GCT = gel column technology;  
EMT = erythrocyte magnetized technology.
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by both GCT and EMT were lower than those by CTT. The 
largest difference between the methods was observed with 
samples for anti-K, in which the titer values by GCT were 1.5 
dilutions higher compared with CTT. Both CTT and EMT 
had equal sensitivity in cases containing anti-c. Overall, the 
mean titers by GCT were 1.1 dilutions higher and those by 
EMT were 0.35 dilutions higher than CTT. A recent study was 
conducted by Finck et al.16 to determine whether GCT yields 
comparable results with the CTT method in titrating Rh and K 
alloantibodies. For most alloantibodies titrated (anti-E, anti-e, 
and anti-c), the GCT generated titer values were less than one 
dilution higher than the value by CTT. The GCT system was 
found to be slightly less sensitive than CTT for anti-D, giving 
titer results that were on average 0.09 dilutions lower. Samples 
with anti-K tended to generate higher titer values in CTT.
Titer values alone are said to be misleading without 
evaluating the strength of agglutination as well. The observed 
strength of agglutination is assigned a number, and the sum 
of these numbers for all tubes in a titration study represents 
the score, which is another semiquantitative measurement 
of antibody reactivity.1 The arbitrarily assigned threshold for 
significance in comparing scores is a difference of 10 or more. 
In the present study, the mean difference in scores of GCT and 
CTT was more than 10 and, hence, significant. On the other 
hand, the mean difference in scores of EMT and CTT was 
4.88, thus indicating that the strength of reaction with these 
two methods does not differ significantly.
Antibody titration has long been found difficult to 
standardize and to reproduce precisely. This finding is 
exemplified by the AABB recommendation that antenatal 
evaluations of maternal antibodies should be performed on 
previously frozen serum samples in parallel with a current 
specimen to minimize the possibility that changes in the titer 
result from differences in method and in the skill of the testing 
technologist.1 Such duplicate testing mitigates the problem 
of imprecision within a laboratory. The disparity in titration 
results is also reported in proficiency testing samples provided 
in the antibody titration survey of the College of American 
Pathologists.17 Results from different laboratories were 
grouped according to the method used, and the variations 
extended over five or more dilutions (i.e., a 32-fold difference, 
for both anti-D and anti-A).
On comparing the precision of various methods in terms 
of both titer and score in the present study, GCT was found to 
have the best reproducibility. This method reported identical 
titers in 92 percent of cases and identical scores in 78 percent 
of cases. CTT was found to be the least precise, with few cases 
having titer difference of three dilutions and a score difference 
of more than 10. EMT had intermediate precision, with 
identical titers in 76 percent and identical scores in 64 percent 
of the cases. Judd et al.18 suggested that reproducible grading 
is well known to be problematic, even among technical staff 
in a single laboratory, and this apparently is a major source of 
discrepancy when reading titers. An international study was 
conducted by AuBuchon et al.19 in which they reported that 
the gel card method at the AHG phase (1+ end point) showed 
reduced variance compared with tube-based methods. This 
high precision of GCT may be attributed to the clear-cut 
grading of the results.
There were several limitations in this study. First, we 
could not perform a clinical correlation of the titer values. 
Second, the reagent RBCs for antibody titration by EMT were 
procured commercially from the manufacturer, although 
their phenotype was identical to the in-house RBCs used 
for CTT and GCT. Third, testing by EMT was performed 
on an automated platform, whereas the other methods were 
performed manually. Finally, the manufacturers of GCT and 
EMT do not include their application for antibody titration in 
the product literature, which thereby constitutes off-label use 
of these methods.
In conclusion, the titers obtained by GCT were very high 
and not dependable for clinical monitoring of patients. Titers 
obtained by EMT were somewhat similar to CTT, yet their 
reliability for clinical application remains to be determined. 
Precision is another mandate for determining the suitability 
of a method for antibody titration. GCT has been proven best 
in this regard owing to clear-cut interpretation of the results. 
The reproducibility by EMT was comparable with that of GCT 
in most cases. Given its intermediate accuracy and precision, 
EMT may be adopted for performing antibody titration in 
settings where it is currently in use after further validation of 
its performance in studies with larger sample numbers.
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